🎧Check out my new podcast / blog on leadership in global health — with @katribertram.bsky.social 👇🏻

open.substack.com/pub/singerp/...

8/ Bottom line: Innovation is welcome, but safeguards are vital. Flexibility must not come at the expense of educational rigour, professional identity & public trust.
Read the full paper here
journals.sagepub.com/doi/full/10....

🧵 1/ NHS England’s Fit for the Future 10-Year Plan is set to transform postgraduate medical education. Flexibility, digital platforms & modular learning sound great, but what’s at stake? @drlkvaughan.bsky.social & I ask some important questions in a new paper in J Roy Soc Med

🧵1/ Romania has the highest cervical cancer incidence & mortality in Europe. Yet screening coverage is under 30%. Why? Our new study explores the emotional & practical barriers faced by vulnerable women.
@cbigscreen.bsky.social @horizoneu.bsky.social

What am I missing? An increase in NICE’s cost effectiveness threshold from £30 to £35k is 16%. From £20 to £25k is 25%. But if drug prices (cost) increase by 25% then surely there’s no change or, in effect, a lower threshold? If only we could actually read the “deal” …

🆕 Our new piece in @nejm.org, written with colleagues in 2 PEPFAR countries—Zambia & South Africa—& at Duke examines the new US approach to global health

“A retreat from multilateralism, a geopolitical emphasis, and rushed transitions could threaten progress,” we say

www.nejm.org/doi/full/10....